Bulgaria’s pharmaceutical market grew by 6.9% on the year to 619 million levs ($438 million/317 million euro) in the first quarter of 2014, market research firm IMS Bulgaria said.
The pharmacy segment grew 5.0% on the year to 520 million levs, while the hospital segment expanded by 18% on the year, reaching 99 million levs, IMS Bulgaria said in a press release.
“The key growing therapy areas of the Total market in Q1 of 2014 were oncology, diabetes, biologics, anti-infectives and anti-thrombotics,” it added.
The over-the-counter (OTC) market rose by an annual 5.3% to 153 million levs in the three months through March as cold and respiratory remedies posted growth of nearly 11% to 48 million levs, whereas nutritional supplements saw an increase by 9.0% to 14 million levs. Pain relievers generated 28 million levs in sales in the first quarter of the year, down by 3.3% from the same period in 2013.